PRUDENTIAL FINANCIAL INC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 113 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$3,277,000
+16.2%
259,245
-9.7%
0.01%
+20.0%
Q3 2020$2,820,000
-7.9%
287,195
-6.6%
0.01%
-16.7%
Q2 2020$3,061,000
+6.5%
307,632
-5.4%
0.01%0.0%
Q1 2020$2,875,000
-15.3%
325,193
-11.6%
0.01%
+20.0%
Q4 2019$3,393,000
+51.5%
367,793
-3.5%
0.01%
+25.0%
Q3 2019$2,239,000
-47.0%
380,949
+8.1%
0.00%
-42.9%
Q2 2019$4,228,000
+167.8%
352,338
+169.3%
0.01%
+133.3%
Q1 2019$1,579,000
+54.2%
130,826
+60.3%
0.00%
+50.0%
Q4 2018$1,024,000
-13.8%
81,616
+2.0%
0.00%0.0%
Q3 2018$1,188,000
-14.8%
80,006
-3.4%
0.00%0.0%
Q2 2018$1,395,000
-17.6%
82,862
+12.1%
0.00%
-33.3%
Q1 2018$1,693,000
+27.3%
73,904
+43.7%
0.00%
+50.0%
Q4 2017$1,330,000
+38.8%
51,443
-20.7%
0.00%
+100.0%
Q3 2017$958,000
-30.4%
64,910
-34.2%
0.00%
-50.0%
Q2 2017$1,376,000
-68.1%
98,630
-61.0%
0.00%
-71.4%
Q1 2017$4,319,000
+109.2%
253,130
+26.2%
0.01%
+133.3%
Q4 2016$2,065,000
-2.0%
200,630
-3.8%
0.00%0.0%
Q3 2016$2,108,000
-18.7%
208,530
-9.7%
0.00%
-25.0%
Q2 2016$2,594,000
-21.5%
230,990
-4.5%
0.00%
-33.3%
Q1 2016$3,303,000
-19.8%
241,790
+11.4%
0.01%
-14.3%
Q4 2015$4,118,000
+136.1%
217,100
+133.7%
0.01%
+133.3%
Q3 2015$1,744,00092,9000.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
BVF INC/IL 2,253,000$7,097,0000.26%
INGALLS & SNYDER LLC 1,358,573$4,280,0000.19%
RA Capital Management 3,033,603$9,556,0000.17%
Kensington Investment Counsel, LLC 85,483$269,0000.16%
Perceptive Advisors 4,301,282$13,548,0000.10%
NewEdge Wealth, LLC 381,326$1,201,0000.05%
Black Diamond Financial, LLC 46,000$145,0000.05%
Birchview Capital, LP 20,000$63,0000.04%
XTX Topco Ltd 14,305$45,0000.02%
Alyeska Investment Group, L.P. 548,090$1,726,0000.02%
View complete list of CONCERT PHARMACEUTICALS INC shareholders